Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichi Suda

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|September 16, 2015
Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplificationKoh Furugaki, Junko Fukumura, Toshiki Iwai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Prognostic impact of pleural lavage cytology in patients with primary lung cancerKenji Tomizawa, Masaya Nishino, Yuichi Sesumi, et al.
Cell Communication and Signaling : CCS|May 11, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12CMasaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Lung Cancer (Amsterdam, Netherlands)|November 6, 2021
In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trialAkira Hamada, Kenichi Suda, Takamasa Koga, et al.
Surgery Today|February 2, 2019
Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysisKenji Tomizawa, Katsuaki Sato, Shuta Ohara, et al.
Biomed Research International|November 10, 2017
Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell LinesKenichi Suda, Leslie Rozeboom, Koh Furugaki, et al.
Aging and Disease|December 20, 2012
Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger CounterpartsKenichi Suda, Kenji Tomizawa, Hiroshi Mizuuchi, et al.
Molecular Cancer Therapeutics|July 28, 2018
CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung CancerKenichi Suda, Isao Murakami, Hui Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancerKenji Tomizawa, Shigeki Shimizu, Shuta Ohara, et al.
Surgery Today|May 16, 2020
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancerShuta Ohara, Kenichi Suda, Kenji Tomizawa, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|September 16, 2015
Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplificationKoh Furugaki, Junko Fukumura, Toshiki Iwai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Prognostic impact of pleural lavage cytology in patients with primary lung cancerKenji Tomizawa, Masaya Nishino, Yuichi Sesumi, et al.
Cell Communication and Signaling : CCS|May 11, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12CMasaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Lung Cancer (Amsterdam, Netherlands)|November 6, 2021
In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trialAkira Hamada, Kenichi Suda, Takamasa Koga, et al.
Surgery Today|February 2, 2019
Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysisKenji Tomizawa, Katsuaki Sato, Shuta Ohara, et al.
Biomed Research International|November 10, 2017
Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell LinesKenichi Suda, Leslie Rozeboom, Koh Furugaki, et al.
Aging and Disease|December 20, 2012
Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger CounterpartsKenichi Suda, Kenji Tomizawa, Hiroshi Mizuuchi, et al.
Molecular Cancer Therapeutics|July 28, 2018
CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung CancerKenichi Suda, Isao Murakami, Hui Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancerKenji Tomizawa, Shigeki Shimizu, Shuta Ohara, et al.
Surgery Today|May 16, 2020
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancerShuta Ohara, Kenichi Suda, Kenji Tomizawa, et al.
Pageof 13